Position in ACAD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,880,087
-$6,419,266 QoQ
Shares Held
129,384
-62.8% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 86.23709268533976.ToString("F0")%
Shared 0.ToString("F0")%
None 13.762907314660236.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Man Group plc holds $1,080,100,046 across 125 Biotechnology names. ACAD ranks #41 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
315,212 | $243,545,399 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
236,798 | $105,739,778 | |
| 3 | INCY |
Incyte Corp
|
930,171 | $87,547,693 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
232,369 | $76,883,931 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
241,922 | $71,843,576 | |
| 6 | APLS |
Apellis Pharmaceuticals, Inc.
|
915,689 | $36,838,167 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
275,270 | $26,770,006 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
135,212 | $25,561,828 |
All Filings in ACAD
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,880,087 | 129,384 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,299,353 | 348,160 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $8,048,870 | 377,173 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,189,144 | 286,933 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,260,841 | 196,318 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $22,405,753 | 1,221,022 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $19,616,158 | 1,275,433 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $928,606 | 57,145 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $930,065 | 50,301 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,008,808 | 32,220 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,651,777 | 79,260 | Principal | Defined | 2023-11-14 | |
| 2023-06-30 | $6,638,843 | 277,196 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $12,737,225 | 676,792 | Principal | Defined | 2023-05-15 | |
| 2022-12-31 | $15,214,551 | 955,688 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $379,305 | 23,185 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $470,739 | 19,436 | Shares | Defined | 2022-05-16 | |
| 2020-12-31 | $2,679,896 | 50,129 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,444,475 | 59,260 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $5,594,407 | 115,420 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,094,966 | 49,585 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||